NCT02597699View on ClinicalTrials.gov

Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

December 18, 2015

Primary Completion Date

March 7, 2019

Study Completion Date

May 6, 2019

Conditions
Termination of PregnancyFeticide
Interventions
DRUG

Remifentanil + Lidocaïne

DRUG

Sufentanil + Lidocaïne

Trial Locations (2)

30029

Nîmes University Hospital, Nîmes

34295

Hôpital Arnaud de Villeneuve, Montpellier

All Listed Sponsors
collaborator

Centre Hospitalier Universitaire de Nīmes

OTHER

lead

University Hospital, Montpellier

OTHER

NCT02597699 - Use of Ultiva ® Associated With Xylocaine ® in the Procedures of Feticide | Biotech Hunter | Biotech Hunter